Immunome (IMNM) is down -7.2%, or -$1.70 to $21.78.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMNM:
- Immunome 18.625M share Spot Secondary priced at $21.50
- Immunome price target raised to $32 from $22 at Lake Street
- Immunome price target raised to $40 from $18 at Evercore ISI
- Immunome price target raised to $35 from $25 at Guggenheim
- 3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts